News > New close of Health for Life Capital at €100m

New close of Health for Life Capital at €100m

Thursday 26 March 2015

Health for Life Capital, managed by Seventure Partners, realised a new close at €100m.

The aim of Health for Life Capital has been to support innovative high-growth entrepreneurial ventures.

The geographical focus of Health for Life Capital is primarily in Europe, but also extends to North America and Asia. Investment is focused on four areas: microbiota, nutrition, biotech and digital health.

The fund raising has attracted both financial investors, strategic investors and serial entrepreneurs. Jasmin Capital is the placement agent of this fund.

Initial investments have been madein Enterome Bioscience (Paris), LNC (Laboratoires Nutrition & Cardiométabolisme) (Bordeaux), Interface Therapeutics (California, USA), Humedics (Berlin) and MaaT Pharma (Lyon).

Webpage:

Contact | Conception | Site Map